Federal Supply Schedule 36F79722D0161
Award Date
7/1/22
Last Date to Order
6/30/27
Federal Agency
Veterans Integrated Service Network 12
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The U.S. Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) worth up to $2,500,000 to Amneal Pharmaceuticals of New York, LLC, a for-profit limited liability company that manufactures pharmaceutical products. The BPA is for the provision of the generic drug sodium oxybate, which is used to treat narcolepsy. Amneal Pharmaceuticals holds several indefinite delivery vehicle (IDV) contracts with federal agencies, including a 5-year, $1,700,000 Federal Supply...
The Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) to Jazz Pharmaceuticals, Inc., a global biopharmaceutical company, to provide specialty pharmaceutical products such as Xyrem, Xywav, and sodium oxybate formulations. The BPA, valued at up to $150 million, allows the VA to efficiently procure needed medications to support healthcare services for veterans at VA medical facilities nationwide....
The Department of Veterans Affairs National Acquisition Center awarded a Blanket Purchase Agreement (BPA) to Jazz Pharmaceuticals, Inc. for the delivery of specialty pharmaceutical products, primarily the sleep disorder medication Xyrem. The $150 million BPA is issued under Jazz Pharmaceuticals' Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract, allowing the VA to efficiently procure needed medications for its healthcare facilities. Four task orders worth up to $717,519 have...
Jazz Pharmaceuticals, Inc. holds a $116 million Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB) with the U.S. Department of Veterans Affairs (VA). This allows the VA to efficiently procure specialty pharmaceutical products from Jazz Pharmaceuticals, including sleep disorder treatments such as Xyrem and Xywav. Jazz Pharmaceuticals also holds a $161,183,457.45 Blanket Purchase Agreement with the VA's National Acquisition Center for the procurement of...
The Department of Veterans Affairs awarded a multiple-award federal supply schedule contract to Amryt Pharmaceuticals Inc. with a potential value of $225,000. The schedule is for pharmaceuticals and hematology-related products under contract number 65 IB. This enables ordering through September 2028. Additionally, the Department of Veterans Affairs National Acquisition Center awarded a single-award blanket purchase agreement to Amryt Pharmaceuticals with a value of up to $1,000,000. The BPA...
The Department of Veterans Affairs awarded a Federal Supply Schedule contract to Vyera Pharmaceuticals, LLC to procure drugs, pharmaceuticals, and related hematology products. The potential value of this multiple award schedule is $3.5 million with an ordering period through September 2029. Additionally, the National Acquisition Center established a single award Blanket Purchase Agreement with Vyera Pharmaceuticals on behalf of the Veterans Health Administration. Valued at $450,000, this BPA...
The Department of Veterans Affairs (VA) has awarded a multiple award Federal Supply Schedule (FSS) contract to Xeris Pharmaceuticals, Inc., a small disadvantaged business manufacturer, to provide drugs, pharmaceuticals, and hematology-related products. The contract has a ceiling value of $4,119,200 and a period of performance from July 2020 to April 2026. Under this FSS contract, the VA National Acquisition Center has issued a single award Blanket Purchase Agreement (BPA) to Xeris for the...
The U.S. Department of Veterans Affairs (VA) has awarded a Federal Supply Schedule (FSS) contract to Axsome Therapeutics Inc. for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. The multiple-award contract has a ceiling value of $28,284,570.80 and a period of performance through February 14, 2028. As a for-profit manufacturer, Axsome Therapeutics will provide the VA's Veterans Integrated Service Network 12 with a variety of pharmaceutical and...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Axsome Therapeutics Inc., provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The $25,000 contract has a period of performance through February 28, 2023. As a multiple award FSS, this contract allows for orders to be placed by any federal agency. The contract does not utilize any set-asides. This interim agreement under the FSS facilitates the...
The Department of Veterans Affairs (VA) has awarded a $216 million multiple-award Federal Supply Schedule (FSS) contract to Hikma Pharmaceuticals USA Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the procurement of pharmaceuticals and hematology-related products. The contract, which falls under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, has a period of performance through August 14, 2026. Additionally, Hikma Pharmaceuticals holds a $38.5 million single-award Blanket...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Last Date To Order (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
36F79722D0161-36E79724A0001 | Amneal Pharmaceuticals Of New York, LLC | $2.5m | 10/18/23 | 10/17/25 | 12/9/24 |
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 36F79722D0161-36C26025F0044 | Amneal Pharmaceuticals Of New York, LLC | $173.6k | 11/1/24 | 10/31/25 | 10/4/24 | |
Delivery Order 36F79722D0161-36C26024F0050 | Amneal Pharmaceuticals Of New York, LLC | $185.4k | 11/1/23 | 10/31/24 | 2/7/25 |